Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney CancerEur Urol Oncol 2021 Dec 28;[EPub Ahead of Print], R Hannan, M Christensen, H Hammers, A Christie, B Paulman, D Lin, A Garant, W Arafat, K Courtney, I Bowman, S Cole, D Sher, C Ahn, H Choy, R Timmerman, J Brugarolas
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.